Advertisment

Indian Journal of Nephrology About us |  Subscription |  e-Alerts  | Feedback | Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Current Issue | Archives| Ahead of print | Search |Instructions |  Editorial Board  

Users Online:4259

Official publication of the Indian Society of Nephrology
  Search
 
  
 ~  Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~Related articles
 ~  Article in PDF (1,556 KB)
 ~  Citation Manager
 ~  Access Statistics
 ~  Reader Comments
 ~  Email Alert *
 ~  Add to My List *
* Registration required (free)  

 
   Abstract
  Introduction
  Case Report
  Discussion
   References
   Article Figures

 Article Access Statistics
    Viewed2202    
    Printed49    
    Emailed0    
    PDF Downloaded96    
    Comments [Add]    

Recommend this journal

 


 
  Table of Contents  
CASE REPORT
Year : 2017  |  Volume : 27  |  Issue : 5  |  Page : 389-391
 

Strongyloid hyperinfection in a patient with immunocompromised chronic kidney disease


Department of Nephrology, Care Hospitals, Hyderabad, Telangana, India

Date of Web Publication31-Aug-2017

Correspondence Address:
S Hedau
Care Hospitals, Road No. 1, Banjara Hills, Hyderabad - 500 028, Telangana
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijn.IJN_290_16

Rights and Permissions

  Abstract 


Strongyloid hyperinfection is seen in immunocompromised individuals with underlying lung disease. The use of immunosuppressive drugs is an important risk factor. We report a case of IgA nephropathy with crescent, started on glucocorticoid and mycophenolate mofetil. He presented with bilateral lung opacities with breathlessness. As the breathlessness was not improving, despite adequate ultrafiltration, bronchoscopy was done. Bronchoalveolar lavage fluid examination showed the presence of strongyloid larvae, which was later demonstrated in stool also. He responded to antihelminthic treatment with disappearance of larvae from stool but later developed secondary bacterial infections.


Keywords: CKD, pulmonary strongyloidiasis, strongyloid hyperinfection


How to cite this article:
Hedau S, Reddy V P, Mondhe S D, Devana J V. Strongyloid hyperinfection in a patient with immunocompromised chronic kidney disease. Indian J Nephrol 2017;27:389-91

How to cite this URL:
Hedau S, Reddy V P, Mondhe S D, Devana J V. Strongyloid hyperinfection in a patient with immunocompromised chronic kidney disease. Indian J Nephrol [serial online] 2017 [cited 2022 Jan 25];27:389-91. Available from: https://www.indianjnephrol.org/text.asp?2017/27/5/389/202840





  Introduction Top


Strongyloid stercoralis is often considered a disease of tropical and subtropical areas, though endemic foci are also seen in temperate regions.[1] The parasite is mostly confined to the tropics and subtropics infecting about 100 million people in about seventy countries.[2] Hyperinfection syndrome is not exactly defined, but the hallmark is an increase in the number of larvae in the stool and/or sputum along with manifestations confined to respiratory and gastrointestinal systems along with peritoneum.[3] Hyperinfection syndrome is estimated to happen in 1.5%–2.5% of the patients with strongyloidiasis.[4]


  Case Report Top


A 69-year-old male, a known case of diabetes mellitus, hypertension, and chronic kidney disease (CKD), presented to emergency room (ER) with fever, shortness of breath (SOB), and gross fluid overload. He underwent renal biopsy 4 months back due to rapid worsening of renal parameters (creatinine 4 mg/dl). He was started on immunosuppression (prednisolone and mycophenolate) in view of cresenteric IgA nephropathy on biopsy. He had rapid worsening of renal parameters (creatinine 7 mg/dl) despite 4 months of immunosuppression and initiated on hemodialysis through the right internal jugular vein access. In the next 3 weeks, dialysis was not done and he developed fluid overload.

He presented to ER with fever, SOB, and gross fluid overload. On admission, heart rate was 96/min, respiratory rate was 30/min, and SpO2 was 94%, with 10 liter/min oxygen supplement. His complete blood count revealed anemia with no leukocytosis or eosinophilia. Renal parameters were grossly deranged (urea: 203 mg/dl and creatinine: 6.3 mg/dl). Arterial blood gas showed severe metabolic acidosis (pH 7.29, HCO3 11.9). There was severe hypoalbuminemia (serum albumin: 1.7 g/dl). His chest X-ray showed bilateral diffuse opacities [Figure 1]. His oxygenation was not improving despite adequate dialysis and decongestion. Computed tomography scan of the chest revealed bilateral fluffy opacities involving the lower and middle lobes [Figure 2]. Bronchoalveolar lavage (BAL) fluid showed strongyloid larvae [Figure 3]. Subsequently, stool examination also revealed the presence of strongyloid larvae [Figure 4]. BAL culture was sterile. Blood culture showed Escherichia coli growth. He was started on ivermectin 9 mg and albendazole 200 mg once daily along with meropenem for blood stream infection. Strongyloid larvae became undetectable after 7 days of treatment, and serial chest X-ray showed gradual improvement. Subsequently, he developed right lung consolidation, and repeat blood culture showed Chryseomonas growth. The patient remained sick and ventilator dependent. He finally succumbed to secondary bacterial infection after 2 weeks of admission.
Figure 1: Chest X-ray showing bilateral diffuse opacities

Click here to view
Figure 2: Computed tomography chest showing bilateral fluffy opacities predominantly in the lower and middle lobes

Click here to view
Figure 3: Bronchoalveolar lavage fluid showing strongyloid larvae

Click here to view
Figure 4: Stool examination showing strongyloid larvae

Click here to view



  Discussion Top


The life cycle of Strongyloides stercoralis is distributed between the free-living and parasitic cycles.[3]S. stercoralis is a soil-dwelling nematode and may take one of the two cycles depending on the prevalent conditions and turns parasitic in adverse conditions.[3] The free-living cycle begins with the passage of the rhabditiform larvae in the stool, which, on reaching the soil, molt under favorable conditions to become adult-free living worms. These worms reproduce sexually and produce rhabditiform larvae in turn, which then molt into filariform larvae. The latter forms infect the human host.[3] When a susceptible host is available, the infective filariform larvae penetrate the intact skin, travel to the blood stream through subcutaneous lymphatics, and reach the pulmonary circulation.

Autoinfection is one of the important characteristic features of the life cycle of S. stercoralis. The various life cycle changes in the case of autoinfection are the rhabditiform larvae instead of being shed in the stool molt twice in the body of the host (mainly in the intestine) to become filariform larvae that then penetrate the intestinal wall or perianal skin and reach different organs of the body leading to hyperinfection syndrome if limited to respiratory and gastrointestinal tracts or disseminated infection with involvement of other organ systems.[3]

The hyperinfection syndrome happens from the enormous multiplication and migration of infective larvae, especially in an immunosuppressed state.

Corticosteroids, endogenous as well as exogenous, have been shown to affect the immunity by increasing the apoptosis of Th2 cells, reducing the eosinophil count and inhibiting the mast cell response, thereby leading to hyperinfection or disseminated infection.[1] It is also proposed that both exogenous and endogenous corticosteroids increase steroid-like substances (naturally occurring sterols with nonhormonal anabolic effects) in the body, mainly in the intestinal wall. These substances act as molting signals and lead to increased production of autoinfective filariform larvae leading to hyperinfection and disseminated infection.[5],[6]

The mortality from disseminated infection could be up to 87%.[1],[5],[7] The high mortality rate associated with hyperinfection syndrome and disseminated disease is frequently due to secondary bacterial infections.[8]

For this reason, various authors suggested that steroid-treated patients with chronic lung disease or suspected malignant tumors should be screened for strongyloides infection.[9] Sputum cytology may be the most useful screening procedure,[10] and a BAL may be done to identify the organism in case the sputum is negative for larvae. Although it is a potentially lethal iatrogenic opportunistic infection, it is amenable to treatment with antihelminthic agents if recognized in time. This case illustrates the need to suspect opportunistic pulmonary strongyloidiasis when a patient has immunosuppressed state due to underlying CKD, malnutrition, and exposure to immunosuppressive drugs.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Berk SL, Verghese A, Alvarez S, Hall K, Smith B. Clinical and epidemiologic features of strongyloidiasis. A prospective study in rural Tennessee. Arch Intern Med 1987;147:1257-61.  Back to cited text no. 1
    
2.
Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001;33:1040-7.  Back to cited text no. 2
    
3.
Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 2004;17:208-17.  Back to cited text no. 3
    
4.
Milder JE, Walzer PD, Kilgore G, Rutherford I, Klein M. Clinical features of Strongyloides stercoralis infection in an endemic area of the United States. Gastroenterology 1981;80:1481-8.  Back to cited text no. 4
    
5.
Siddiqui AA, Genta RM, Berk SL. Strongyloides stercoralis. In: Blaser MJ, editor. Textbook of Infections of Gastrointestinal Tract. 2nd ed. Philadelphia: Lippincott Williams and Wilkins; 2002. p. 1113-26.  Back to cited text no. 5
    
6.
Siddiqui AA, Berk SL, Genta RM. Strongyloidiasis. In: Guerrant RL, editor. Textbook of Tropical Infections Diseases: Principles, Pathogens, and Practice. 2nd ed. Philadelphia: Elsevier; 2005. p. 1274-85.  Back to cited text no. 6
    
7.
Lim S, Katz K, Krajden S, Fuksa M, Keystone JS, Kain KC. Complicated and fatal Strongyloides infection in Canadians: Risk factors, diagnosis and management. CMAJ 2004;171:479-84.  Back to cited text no. 7
    
8.
Link K, Orenstein R. Bacterial complications of strongyloidiasis: Streptococcus bovis meningitis. South Med J 1999;92:728-31.  Back to cited text no. 8
    
9.
Nwokolo C, Imohiosen EA. Strongyloidiasis of respiratory tract presenting as “asthma”. Br Med J 1973;2:153-4.  Back to cited text no. 9
    
10.
Pillai KR, Nair GR, Amma NS, Nair MK. Diagnosis of pulmonary strongyloidiasis by sputum cytology: A case report. Indian J Pathol Microbiol 1993;36:489-91.  Back to cited text no. 10
    


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4]



 

Top
Print this article  Email this article
 

    

Indian Journal of Nephrology
Published by Wolters Kluwer - Medknow
Online since 20th Sept '07